DCM-FLNC

N/A

Report date: 2025/09/08 17:54:53

Base Information

Drug NameDCM-FLNC
Drug Alias NameDCM-FLNC
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionFilamin-A modulators
TargetsFilamin-A
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTevard Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTevard Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A